HRTX - Heron Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.67
DETAILS
HIGH:
$9.00
LOW:
$5.00
MEDIAN:
$6.00
CONSENSUS:
$6.67
UPSIDE:
1499.90%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 2,600,990 | $2.1M | 0.0% | -403,650 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-16 | Duarte Ira | officer: EVP, Chief Financial Officer | M-Exempt | 12,500 | -- | -- |
| 2026-06-16 | Duarte Ira | officer: EVP, Chief Financial Officer | F-InKind | 3,555 | $0.38 | $1K |
| 2026-06-06 | Forbes William P | officer: EVP, Chief Development Officer | M-Exempt | 12,500 | -- | -- |
| 2026-05-06 | Hensley Mark Earl | officer: Chief Operating Officer | M-Exempt | 125,000 | -- | -- |
| 2026-04-30 | Forbes William P | officer: EVP, Chief Development Officer | M-Exempt | 11,694 | -- | -- |
| 2026-04-30 | Duarte Ira | officer: EVP, Chief Financial Officer | M-Exempt | 11,694 | -- | -- |
| 2026-04-30 | Hensley Mark Earl | officer: Chief Operating Officer | M-Exempt | 11,770 | -- | -- |
| 2026-04-30 | Forbes William P | officer: EVP, Chief Development Officer | M-Exempt | 11,770 | -- | -- |
| 2026-04-30 | Duarte Ira | officer: EVP, Chief Financial Officer | M-Exempt | 13,535 | -- | -- |
| 2026-04-30 | Collard Craig A | director, officer: Chief Executive Officer | M-Exempt | 50,021 | -- | -- |
| 2026-04-30 | Collard Craig A | director, officer: Chief Executive Officer | M-Exempt | 34,789 | -- | -- |
| 2026-04-19 | Collard Craig A | director, officer: Chief Executive Officer | M-Exempt | 13,797 | -- | -- |
| 2026-04-19 | Duarte Ira | officer: EVP, Chief Financial Officer | M-Exempt | 3,874 | -- | -- |
| 2026-04-19 | Forbes William P | officer: EVP, Chief Development Officer | M-Exempt | 3,874 | -- | -- |
| 2026-04-03 | Collard Craig A | director, officer: Chief Executive Officer | M-Exempt | 62,500 | -- | -- |
| 2026-01-30 | Collard Craig A | director, officer: Chief Executive Officer | A-Award | 800,337 | -- | -- |
| 2026-01-30 | Christian Waage | director | A-Award | 53,960 | -- | -- |
| 2026-01-30 | Kaseta Michael | director | A-Award | 53,960 | -- | -- |
| 2026-01-30 | Cusack Thomas | director | A-Award | 53,960 | -- | -- |
| 2026-01-31 | Duarte Ira | officer: EVP, Chief Financial Officer | M-Exempt | 11,695 | -- | -- |
| 2026-01-30 | Dissanaike Sharmila | director | A-Award | 53,960 | -- | -- |
| 2026-01-30 | Hensley Mark Earl | officer: Chief Operating Officer | A-Award | 188,315 | -- | -- |
| 2026-01-30 | Collard Craig A | director, officer: Chief Executive Officer | A-Award | 800,336 | -- | -- |
| 2026-01-30 | Duarte Ira | officer: EVP, Chief Financial Officer | A-Award | 216,562 | -- | -- |
| 2026-01-30 | Duarte Ira | officer: EVP, Chief Financial Officer | A-Award | 216,561 | -- | -- |